Back to Search Start Over

R-CHOP in NLPHL: who should receive it?

Authors :
Eichenauer, Dennis A.
Engert, Andreas
Source :
Blood. 7/27/2017, Vol. 130 Issue 4, p387-388. 2p.
Publication Year :
2017

Abstract

In this issue of Blood, Fanale and colleagues report promising treatment results for patients with newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) receiving R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) (see figure). [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
*HODGKIN'S disease
*LYMPHOCYTES
*PATIENTS

Details

Language :
English
ISSN :
00064971
Volume :
130
Issue :
4
Database :
Academic Search Index
Journal :
Blood
Publication Type :
Academic Journal
Accession number :
124385150
Full Text :
https://doi.org/10.1182/blood-2017-05-786301
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details